Skip to main content
. Author manuscript; available in PMC: 2025 Oct 1.
Published in final edited form as: J Acquir Immune Defic Syndr. 2024 Oct 1;97(2):107–116. doi: 10.1097/QAI.0000000000003475

Table 2.

Cox PH regression analyses for factors associated with breakthrough infections among overall population

Effect aHR (95% CI) p-value
Age at fully vaccination (Years)
 18–29 Ref.
 30–39 0.82 (0.62, 1.09) 0.17
 40–49 0.78 (0.58, 1.05) 0.11
 50–59 0.55 (0.40, 0.74) <.0001
 60+ 0.37 (0.26, 0.52) <.0001
Sex
 Female Ref.
 Male 0.68 (0.53, 0.88) 0.003
Race
 White Ref.
 Black 1.18 (0.94, 1.48) 0.16
 Hispanic 1.01 (0.61, 1.68) 0.98
 Other/unknown 0.56 (0.27, 1.16) 0.12
HIV transmission risk
 Heterosexual Ref.
 IDU/MSM 0.99 (0.66, 1.50) 0.97
 MSM 1.12 (0.83, 1.50) 0.46
 Other/unknown 0.95 (0.75, 1.21) 0.67
Residence
 Rural Ref.
 Urban 0.83 (0.68, 1.01) 0.07
History of covid infection prior vaccination
 No Ref.
 Yes 0.82 (0.64, 1.06) 0.13
Vaccine brands
 PFR Ref.
 JSN 0.86 (0.64, 1.17) 0.3427
 MOD 0.78 (0.66, 0.93) 0.0053
 Mix 1.62 (0.23, 11.65) 0.6329
Period
 Alpha Ref.
 Delta 1.50 (1.25, 1.81) <.0001
 Omicron 2.86 (1.73, 4.73) <.0001
Booster received
 No Ref.
 Yes 0.19 (0.15, 0.24) <.0001
Cardiovascular disease
 No Ref.
 Yes 0.78 (0.55, 1.11) 0.17
Chronic pulmonary disease
 No Ref.
 Yes 1.24 (0.98, 1.59) 0.08
Diabetes mellitus
 No Ref.
 Yes 1.47 (1.14, 1.90) 0.00
Renal disease
 No Ref.
 Yes 1.32 (0.93, 1.87) 0.12
Liver disease
 No Ref.
 Yes 0.87 (0.54, 1.41) 0.58
Peptic ulcer disease
 No Ref.
 Yes 0.51 (0.13, 2.06) 0.34
Dementia
 No Ref.
 Yes 0.66 (0.21, 2.10) 0.49
Recent CD4 counts (cells/mm3) *
 <200 Ref.
 200–350 0.61 (0.42, 0.91) 0.01
 351–500 0.69 (0.48, 0.99) 0.05
 >500 0.68 (0.49, 0.94) 0.02
 Unknown 0.43 (0.23, 0.80) 0.01
Recent HIV viral load (copies/ml) *
 <200 Ref.
 ≥200 1.05 (0.87, 1.26) 0.63
 Unknown 1.06 (0.69, 1.63) 0.79
AIDS at full vaccination date
 No
 Yes 0.91 (0.76, 1.10) 0.33

Note.

*

The most recent CD4 count or viral load closest to the fully vaccination date (between 2019 and 2021)